Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v2.4.1.9
Condensed Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Revenues $ 0us-gaap_Revenues $ 0us-gaap_Revenues
Operating expenses:    
Research and development 262,760us-gaap_ResearchAndDevelopmentExpense 111,708us-gaap_ResearchAndDevelopmentExpense
General and administrative 516,986us-gaap_GeneralAndAdministrativeExpense 140,913us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 779,746us-gaap_OperatingExpenses 252,621us-gaap_OperatingExpenses
Operating loss (779,746)us-gaap_OperatingIncomeLoss (252,621)us-gaap_OperatingIncomeLoss
Other income (expense):    
Interest income 1,177us-gaap_InvestmentIncomeInterest 31us-gaap_InvestmentIncomeInterest
Interest expense (1,756)us-gaap_InterestExpense (1,740)us-gaap_InterestExpense
Other expense (891)us-gaap_OtherNonoperatingExpense 0us-gaap_OtherNonoperatingExpense
Amortization of debt discount (49)us-gaap_AmortizationOfDebtDiscountPremium (80)us-gaap_AmortizationOfDebtDiscountPremium
Total other income (expense) (1,519)us-gaap_NonoperatingIncomeExpense (1,789)us-gaap_NonoperatingIncomeExpense
Net loss $ (781,265)us-gaap_NetIncomeLoss $ (254,410)us-gaap_NetIncomeLoss
Basic and diluted net loss per share $ (0.03)us-gaap_EarningsPerShareBasicAndDiluted $ (0.02)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding - basic and diluted 31,198,876us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 12,915,343us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted